At Fuse Vectors, our mission is to revolutionize AAV gene therapy development.
Fuse Vectors has raised €5.0M across 1 funding round from 1 investor, most recently a Pre-Seed round in Feb 2025. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-25 | Pre-Seed | €5.0M |
| HCVC |
| View deal → |
